Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: A multi-institutional phase II trial

Journal of Thoracic Oncology

Volumn 2, Issue 1, 2007, Pages 65-68

  Maruyama, Riichiroh ^a   Yokoyama, Hideki ^a   Seto, Takashi ^a,b   Nagashima, Seiji ^a,c   Kashiwabara, Kosuke ^a,d   Araki, Jun ^a,e   Semba, Hiroshi ^a,b   Ichinose, Yukito ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KUMAMOTO REGIONAL MEDICAL CENTER   (Japan)

^c Sasebo Shiritsu Sogo Hospital   (Japan)

^d Taragi Municipal Hospital   (Japan)

^e Yamaguchi Grand Medical Center   (Japan)

Author keywords

Bleomycin; Malignant pericardial effusion; Multi institutional phase II trial; Non small cell lung cancer; Pericardial drainage

Indexed keywords

BLEOMYCIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; ARTICLE; CATHETER; CATHETER REMOVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DEATH; DRUG FEVER; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PERICARDIAL EFFUSION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURGICAL DRAINAGE; SURVIVAL TIME; TREATMENT OUTCOME; INDWELLING CATHETER; LUNG TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE; WOUND DRAINAGE;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARCINOMA, NON-SMALL-CELL LUNG; CATHETERS, INDWELLING; COMBINED MODALITY THERAPY; DRAINAGE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; SURVIVAL RATE;

EID: 34249743814     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31802c8260     Document Type: Article

References (23)

1. Fraser RS, Viloria JB, Wang NS. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 1980;45:1697-1704.
2. Shepherd FA, Morgan C, Evans WK, et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987;60:1161-1166.
3. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637-643.
4. Liu G, Crump M, Goss PE, et al. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996;14:3141-3147.
5. Imamura T, Tamura K, Takenaga M, et al. Intrapericardial OK-432 instillation for the management of malignant pericardial effusion. Cancer 1991;68:259-263.
6. Tomkowski W, Szturmowicz M, Fijalkowska A, et al. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol 1994;120:434-436.
7. Koester WM, Winkelmann M. Intrapericardial cisplatin therapy of malignant pericardial effusions. Eur J Cancer 1994;30A:131-132.
8. Tondini M, Rocco G, Bianchi C, et al. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 1995;50:86-88.
9. Moriya T, Takiguchi Y, Tabeta H, et al. Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer. Br J Cancer 2000;83:858-862.
10. Lerner-Tung MB, Chang AY, Ong LS, et al. Pharmacokinetics of intrapericardial administration of 5-fluorouracil. Cancer Chemother Pharmacol 1997;40:318-320.
11. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997;64:1422-1427; discussion 1427-1428.
12. Colleoni M, Martinelli G, Beretta F, et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and welltolerated regimen. J Clin Oncol 1998;16:2371-2376.
13. Martinoni A, Cipolla CM, Cardinale D, et al. Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. Chest 2004;126:1412-1416.
14. Kawashima O, Kurihara T, Kamiyoshihara M, et al. Management of malignant pericardial effusion resulting from recurrent cancer with local instillation of aclarubicin hydrochloride. Am J Clin Oncol 1999;22:396-398.
15. Primrose WR, Clee MD, Johnston RN. Malignant pericardial effusion managed with vinblastine. Clin Oncol 1983;9:67-70.
16. Maher ER, Buckman R. Intrapericardial installation of bleomycin in malignant pericardial effusion. Am Heart J 1986;111:613-614.
17. Yano T, Yokoyama H, Inoue T, et al. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994;51:507-509.
18. Paladine W, Cunningham TJ, Sponzo R, et al. Intracavitary bleomycin in the management of malignant effusions. Cancer 1976;38:1903-1908.
19. Ostrowski MJ, Halsall GM. Intracavitary bleomycin in the management of malignant effusions: a multicenter study. Cancer Treat Rep 1982;66:1903-1907.
20. Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982;38:143-151.
21. Kopecky SL, Callahan JA, Tajik AJ, et al. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol 1986;58:633-635.
22. Alcan KE, Zabetakis PM, Marino ND, et al. Management of acute cardiac tamponade by subxiphoid pericardiotomy. JAMA 1982;247:1143-1148.
23. Osuch JR, Khandekar JD, Fry WA. Emergency subxiphoid pericardial decompression for malignant pericardial effusion. Am Surg 1985;51:298-300.